Skip to content

Construct stability with the use of cones in revision total knee arthroplasty measured with RSA

Construct stability with the use of cones in revision total knee arthroplasty measured with RSA - Cones RSA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52619
Enrollment
25
Registered
2018-11-21
Start date
2019-10-24
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative joint disease knee osteoarthritis

Interventions

The study intervention is the hybrid fixation of Legion revision TKA with cones as used in regular clinical practice.

Sponsors

Sint Maartenskliniek
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Patients requiring a (re-(re-))revision of their total knee arthroplasty and the Legion system with the use of a cone in the tibia because of metaphyseal bone loss. • Patient is willing to consent to participate in the study. • Patient is

Exclusion criteria

Exclusion criteria: • Indication for a hinged-type revision system. • Active, local infection or systemic infection. • Patient has physical, emotional, or neurological conditions that would compromise the patient*s compliance with postoperative rehabilitation and follow-up. • Patient has an immunosuppressive disorder (including inflammatory arthritis). • Patient has a known sensitivity to materials in the device.

Design outcomes

Primary

MeasureTime frame
The primary endpoint of this study is the stability of the revision construct with cones at two and five years. Stability is measured and will be described by migration of the implant with regard to the (RSA markers in the) bone.

Secondary

MeasureTime frame
The secundary endpoint is the survival of the revised TKA system. Additionally, clinical and functional performance will be evaluated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)